Table:
begin	end	state
1	5	non-cytoplasmic
6	22	transmembrane
23	28	cytoplasmic
29	53	transmembrane
54	59	non-cytoplasmic
60	79	transmembrane
80	101	cytoplasmic
102	132	transmembrane
133	138	non-cytoplasmic
139	158	transmembrane
159	177	cytoplasmic
178	198	transmembrane
199	229	non-cytoplasmic
230	252	transmembrane
253	262	cytoplasmic
263	285	transmembrane
286	304	non-cytoplasmic
305	325	transmembrane
326	344	cytoplasmic
345	368	transmembrane
369	386	non-cytoplasmic
387	410	transmembrane
411	421	cytoplasmic
422	444	transmembrane
445	447	non-cytoplasmic

Input:
>AO353_25205
MTPTYSLLTLGASILLIVVLIGKFRVHPFLSLIAASLLVGIGTGMAPTAIVSAFEKGMGS
TLGFLAGIIGLGSILGKLLEESGGAKRIATTLLRVLGEKNASWAMMLVGFIAGIPVFFEV
GFVLLIPLIYVVARQTRINVLYLGVPLAISLMVVHCILPPHPAATAITGMLNADIGKVIL
YGLIVGLPTAVIAGPIWVRLTCTREAPEGQAQFLAARSEAVIDDSKAPSFGIAMVTVLLP
LALMVGKTLAAPLLTKGSMTLEWVSFIGNPLIALALSICFAYWSLGLRRGLGMGALLNLT
NRCFPPLAGILLIIGAGGAFNDMLVGSGIGKALADVLGQSQINPIILAWLIAGLMHFAVG
SATVAMISTAGMVLPILGQHPEYSPEILVIAIGAGAIGWTHVTDSAFWVVKEYLGIPLSE
AIKKFTGATVLASSAALVFTLILSRFV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server